Viropro, Inc. (VPRO)

[gapshot]

is a pharmaceutical company. The company is engaged in the business of marketing technological transfers. The company is operational in South America, Asia and North Africa. The company has various strategic alliances. The company is based out of Canada. The company has announced that it has entered into a definitive agreement with Spectrum Pharmaceuticals. The agreement is with regards to the development of a Rituximab biosimilar. The company also said that it has accepted the resignation of Mr. Serge Beausoleil from the board member position.

This corporate profile is provided for information purposes only and should not be used as the basis for any investment decision. We are neither licensed nor qualified to provide investment advice. We were not paid, nor do we hold a position in these stocks. We reserve the right to buy or sell any stock mentioned in this report at any time after this post.